{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:28:24Z","timestamp":1793212104187,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"a Grant-in-Aid from the Ministry of Education, Science, Technology, Sports and Culture of Japan","award":["15K08432"],"award-info":[{"award-number":["15K08432"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13075-018-1523-1","type":"journal-article","created":{"date-parts":[[2018,2,8]],"date-time":"2018-02-08T07:18:58Z","timestamp":1518074338000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Anti-CD11b antibody treatment suppresses the osteoclast generation, inflammatory cell infiltration, and autoantibody production in arthritis-prone Fc\u03b3RIIB-deficient mice"],"prefix":"10.1186","volume":"20","author":[{"given":"Mareki","family":"Ohtsuji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingshun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Okazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuko","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Amano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Yagita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachiko","family":"Hirose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,8]]},"reference":[{"key":"1523_CR1","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1177\/43.12.8537635","volume":"43","author":"JR Connor","year":"1995","unstructured":"Connor JR, Dodds RA, James IE, Gowen M. Human osteoclast and giant cell differentiation: the apparent switch from nonspecific esterase to tartrate resistant acid phosphatase activity coincides with the in situ expression of osteopontin mRNA. J Histochem Cytochem. 1995;43:1193\u2013201.","journal-title":"J Histochem Cytochem."},{"key":"1523_CR2","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1002\/1529-0131(199908)42:8<1588::AID-ANR4>3.0.CO;2-S","volume":"42","author":"RA Dodds","year":"1999","unstructured":"Dodds RA, Connor JR, Drake FH, Gowen M. Expression of cathepsin K messenger RNA in giant cells and their precursors in human osteoarthritic synovial tissues. Arthritis Rheum. 1999;42:1588\u201393.","journal-title":"Arthritis Rheum."},{"key":"1523_CR3","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature01658","volume":"423","author":"W Boyle","year":"2003","unstructured":"Boyle W, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature. 2003;423:337\u201342.","journal-title":"Nature."},{"key":"1523_CR4","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1038\/nri1733","volume":"5","author":"S Gordon","year":"2005","unstructured":"Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol. 2005;5:953\u201364.","journal-title":"Nat Rev Immunol."},{"key":"1523_CR5","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/nrrheum.2009.217","volume":"5","author":"H Takayanagi","year":"2009","unstructured":"Takayanagi H. Osteoimmunology and the effect of the immune system on bone. Nat Rev Rheumatol. 2009;5:667\u201376.","journal-title":"Nat Rev Rheumatol."},{"key":"1523_CR6","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1146\/annurev.immunol.24.021605.090646","volume":"24","author":"MC Walsh","year":"2006","unstructured":"Walsh MC, Kim N, Kadono Y, Rho J, Lee SY, Lorenzo J, et al. Osteoimmunology: interplay between the immune system and bone metabolism. Annu Rev Immunol. 2006;24:33\u201363.","journal-title":"Annu Rev Immunol."},{"key":"1523_CR7","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1084\/jem.20061775","volume":"203","author":"K Sato","year":"2006","unstructured":"Sato K, Suematsu A, Okamoto K, Yamaguchi A, Morishita Y, Kadono Y, et al. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med. 2006;203:2673\u201382.","journal-title":"J Exp Med."},{"key":"1523_CR8","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","volume":"89","author":"WS Simonet","year":"1997","unstructured":"Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell. 1997;89:309\u201319.","journal-title":"Cell."},{"key":"1523_CR9","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/nri2094","volume":"7","author":"JB Mclnnes","year":"2007","unstructured":"Mclnnes JB, Schett G. Cytokines in the pathogeneses of rheumatoid arthritis. Nat Rev Immunol. 2007;7:429\u201342.","journal-title":"Nat Rev Immunol."},{"key":"1523_CR10","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.1002\/art.30485","volume":"63","author":"A Sato-Hayashizaki","year":"2011","unstructured":"Sato-Hayashizaki A, Ohtsuji M, Lin Q, Hou R, Ohtsuji N, Nishikawa K, et al. Presumptive role of 129 strain-derived Sle16 locus in rheumatoid arthritis in a new mouse model with Fc\u03b3 receptor Type IIb-deficient C57BL\/6 genetic background. Arthr Rheum. 2011;63:2930\u20138.","journal-title":"Arthr Rheum."},{"key":"1523_CR11","doi-asserted-by":"publisher","first-page":"931","DOI":"10.3109\/14397595.2014.886351","volume":"24","author":"H Okazaki","year":"2014","unstructured":"Okazaki H, Lin Q, Nishikawa K, Ohtsuji N, Tsurui H, Ohtsuji M, et al. TNF\u03b1 but not IL-17 is critical in the pathogenesis of rheumatoid arthritis spontaneously occurring in a unique Fc\u03b3RIIB-deficient mouse model. Mod Rheumatol. 2014;24:931\u20138.","journal-title":"Mod Rheumatol."},{"key":"1523_CR12","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3109\/14397595.2014.950035","volume":"25","author":"M Ohtsuji","year":"2015","unstructured":"Ohtsuji M, Lin Q, Nishikawa K, Ohtsuji N, Okazaki H, Tsurui H, et al. IL-6 signal blockade ameliorates the enhanced osteoclastogenesis and the associated joint destruction in a novel Fc\u03b3RIIB-deficient rheumatoid arthritis mouse model. Mod Rheumatol. 2015;25:270\u20137.","journal-title":"Mod Rheumatol."},{"key":"1523_CR13","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1084\/jem.166.6.1685","volume":"166","author":"H Rosen","year":"1987","unstructured":"Rosen H, Gordon S. Monoclonal antibody to the murine type 3 complement receptor inhibits adhesion of myelomonocytic cells in vitro and inflammatory cell recruitment in vivo. J Exp Med. 1987;166:1685\u2013701.","journal-title":"J Exp Med."},{"key":"1523_CR14","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.4049\/jimmunol.167.3.1601","volume":"167","author":"BT Wipke","year":"2001","unstructured":"Wipke BT, Allen PM. Essential role of neutrophils in the initiation and progression of a murine model of rheumatoid arthritis. J Immunol. 2001;167:1601\u20138.","journal-title":"J Immunol."},{"key":"1523_CR15","doi-asserted-by":"publisher","first-page":"316","DOI":"10.3109\/s10165-009-0166-0","volume":"19","author":"Y Abe","year":"2009","unstructured":"Abe Y, Ohtsuji M, Ohtsuji N, Lin Q, Tsurui H, Nakae S, et al. Ankylosing enthesitis associated with up-regulated IFN-\u03b3 and IL-17 production in (BXSB x NZB) F1 male mice: a new mouse model. Mod Rheumatol. 2009;19:316\u201322.","journal-title":"Mod Rheumatol."},{"key":"1523_CR16","doi-asserted-by":"publisher","first-page":"4448","DOI":"10.1111\/j.1742-4658.2008.06580.x","volume":"275","author":"T Iwamoto","year":"2008","unstructured":"Iwamoto T, Okamoto H, Toyama Y, Momohara S. Molecular aspects of rheumatoid arthritis: chemokines in the joints of patients. FEBS J. 2008;275:4448\u201355.","journal-title":"FEBS J."},{"key":"1523_CR17","doi-asserted-by":"publisher","first-page":"3240","DOI":"10.4049\/jimmunol.176.5.3240","volume":"176","author":"S Kikuchi","year":"2006","unstructured":"Kikuchi S, Santiago-Raber M-L, Amano H, Amano E, Fossati-Jimack L, Moll T, et al. Contribution of NZB autoimmunity 2 to Y-linked autoimmune acceleration-induced monocytosis in association with murine systemic lupus. J Immunol. 2006;176:3240\u20137.","journal-title":"J Immunol."},{"key":"1523_CR18","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1093\/rheumatology\/ken363","volume":"47","author":"M Hashizume","year":"2008","unstructured":"Hashizume M, Hayakawa N, Mihara M. IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-\u03b1 and IL-17. Rheumatology. 2008;47:1635\u201340.","journal-title":"Rheumatology."},{"key":"1523_CR19","doi-asserted-by":"crossref","first-page":"6113","DOI":"10.4049\/jimmunol.161.11.6113","volume":"161","author":"TJ Yun","year":"1998","unstructured":"Yun TJ, Chaudhary PM, Shu GL, Frazer JK, Ewing MK, Schwartz SM, et al. OPG\/FDCR-1, a TNF receptor family member, is expressed in lymphoid cells and is up-regulated by ligating CD40. J Immunol. 1998;161:6113\u201321.","journal-title":"J Immunol."},{"key":"1523_CR20","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1002\/jcp.20354","volume":"204","author":"ACW Zannettio","year":"2005","unstructured":"Zannettio ACW, Holding CA, Diamond P, Atkins GJ, Kostakis P, Farrugia A, et al. Osteoprotegerin (0PG) is localized to the Weibel-Palade bodies of human vascular endothelial cells and is physically associated with von Willebrand factor. J Cell Physiol. 2005;204:714\u201323.","journal-title":"J Cell Physiol."},{"key":"1523_CR21","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/art.21528","volume":"54","author":"AI Catrina","year":"2006","unstructured":"Catrina AI, Klint E, Ernestam S, Catrina S-B, Makrygiannakis D, Botusan IR, et al. Anti-tumor necrosis factor therapy increases synovial osteoprotegerin expression in rheumatoid arthritis. Arthritis Rheum. 2006;54:76\u201381.","journal-title":"Arthritis Rheum."},{"key":"1523_CR22","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/nri856","volume":"2","author":"T Takai","year":"2002","unstructured":"Takai T. Roles of Fc receptors in autoimmunity. Nat Rev Immunol. 2002;2:580\u201392.","journal-title":"Nat Rev Immunol."},{"key":"1523_CR23","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1146\/annurev.immunol.19.1.275","volume":"19","author":"JV Ravetch","year":"2001","unstructured":"Ravetch JV, Bolland S. IgG Fc receptors. Annu Rev Immunol. 2001;19:275\u201390.","journal-title":"Annu Rev Immunol."},{"key":"1523_CR24","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S1074-7613(00)00027-3","volume":"13","author":"S Bolland","year":"2000","unstructured":"Bolland S, Ravetch JV. Spontaneous autoimmune disease in Fc\u03b3RIIB-deficient mice results from strain-specific epistasis. Immunity. 2000;13:277\u201385.","journal-title":"Immunity."},{"key":"1523_CR25","doi-asserted-by":"publisher","first-page":"16163","DOI":"10.1074\/jbc.M412713200","volume":"280","author":"MS Kim","year":"2005","unstructured":"Kim MS, Day CJ, Morrison NA. MCP-1 is induced by receptor activator of nuclear factor-\u03baB ligand, promotes human osteoclast fusion, and rescues granulocyte macrophage colony-stimulating factor suppression of osteoclast formation. J Biol Chem. 2005;280:16163\u20139.","journal-title":"J Biol Chem."},{"key":"1523_CR26","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S1074-7613(03)00174-2","volume":"19","author":"F Geissmann","year":"2003","unstructured":"Geissmann F, Jung S, Littman DR. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity. 2003;19:71\u201382.","journal-title":"Immunity."},{"key":"1523_CR27","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1002\/art.24787","volume":"60","author":"M-L Santiago-Raber","year":"2009","unstructured":"Santiago-Raber M-L, Amano H, Amano E, Baudino L, Otani M, Lin Q, et al. Fc\u03b3R-dependent expansion of a hyperactive monocyte subset in lupus-prone mice. Arthritis Rheum. 2009;60:2408\u201317.","journal-title":"Arthritis Rheum."},{"key":"1523_CR28","doi-asserted-by":"publisher","first-page":"11846","DOI":"10.1074\/jbc.M512624200","volume":"281","author":"Z Yao","year":"2006","unstructured":"Yao Z, Li P, Zhang Q, Schwarz EM, Keng P, Arbini A, et al. Tumor necrosis factor-\u03b1 increases circulating osteoclast precursor numbers by promoting their proliferation and differentiation in the bone marrow through up-regulation of c-Fms expression. J Biol Chem. 2006;281:11846\u201355.","journal-title":"J Biol Chem."},{"key":"1523_CR29","doi-asserted-by":"publisher","first-page":"10729","DOI":"10.1073\/pnas.1301001110","volume":"110","author":"M Seeling","year":"2013","unstructured":"Seeling M, Hillenhoff U, David JP, Schett G, Tuckermann J, Lux A, et al. Inflammatory monocytes and Fc\u03b3 receptor IV on osteoclasts are critical for bone destruction during inflammatory arthritis in mice. Proc Nalt Acad Sci USA. 2013;110:10729\u201334.","journal-title":"Proc Nalt Acad Sci USA."},{"key":"1523_CR30","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/nri844","volume":"2","author":"F Mackey","year":"2002","unstructured":"Mackey F, Browning JL. BAFF: a fundamental survival factor for B cells. Nat Rev Immunol. 2002;2:465\u201375.","journal-title":"Nat Rev Immunol."},{"key":"1523_CR31","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nri2691","volume":"10","author":"JE Sims","year":"2010","unstructured":"Sims JE, Smith DE. The IL-1 family: regulators of immunity. Nat Rev Immunol. 2010;10:89\u2013102.","journal-title":"Nat Rev Immunol."},{"key":"1523_CR32","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1046\/j.1365-2567.2001.01337.x","volume":"104","author":"S Nakae","year":"2001","unstructured":"Nakae S, Asano M, Horai R, Iwakura Y. Interleukin-1\u03b2, but not interleukin-1\u03b1, is required for T-cell-dependent antibody production. Immunology. 2001;104:402\u20139.","journal-title":"Immunology."},{"key":"1523_CR33","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.4049\/jimmunol.144.8.3028","volume":"144","author":"CR Maliszewski","year":"1990","unstructured":"Maliszewski CR, Sato TA, Vanden Bos T, Waugh S, Dower SK, Slack J, et al. Cytokine receptors and B cell functions. I. Recombinant soluble receptors specifically inhibit IL-1- and IL-4-induced B cell activities in vitro. J Immunol. 1990;144:3028\u201333.","journal-title":"J Immunol."},{"key":"1523_CR34","doi-asserted-by":"publisher","first-page":"11458","DOI":"10.1073\/pnas.96.20.11458","volume":"96","author":"G Senaldi","year":"1999","unstructured":"Senaldi G, Varnum BC, Sarmiento U, Starnes C, Lile J, Scully S, et al. Novel neurotrophin-1\/B cell-stimulation factor-3: a cytokine of the IL-6 family. Proc Nalt Acad Sci USA. 1999;96:11458\u201363.","journal-title":"Proc Nalt Acad Sci USA."},{"key":"1523_CR35","doi-asserted-by":"publisher","first-page":"5690","DOI":"10.4049\/jimmunol.168.11.5690","volume":"168","author":"G Senaldi","year":"2002","unstructured":"Senaldi G, Stolina M, Guo J, Faggioni R, McCabe S, Kaufman SA, et al. Regulatory effects of novel neurotrophin-1\/b cell-stimulating factor-3 (cardiotrophin-like cytokine) on B cell function. J Immunol. 2002;168:5690\u20138.","journal-title":"J Immunol."}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-018-1523-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T18:28:06Z","timestamp":1693506486000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-018-1523-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,8]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1523"],"URL":"https:\/\/doi.org\/10.1186\/s13075-018-1523-1","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,8]]},"assertion":[{"value":"5 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments were approved by the Institutional Animal Care and Use Committee at the Toin University of Yokohama under the protocol reference number D29-16.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that we have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"25"}}